The drug industry is bracing for a surge in the number of shipments it needs to meet the needs of customers across the country.
Indias pharmaceutical manufacturers have announced that they will start delivering a range of drugs in bulk by the middle of the month.
“We will start with about 50,000 tablets to be delivered by the start of next month and we will ramp up in a phased manner,” said Shobha Singh, senior vice president and general manager at GSK.
India, the world’s third-largest drug market, has been grappling with an outbreak of superbugs which has caused some deaths, although officials have said the disease is now under control.
The medicines developed by the multinational drug maker have been made available to customers across India, and they include a vaccine for tuberculosis and a vaccine against hepatitis B. In a press release, GSK said the bulk distribution of its products will begin from February 10.
GSK’s announcement comes as more companies are coming on board to help India meet the drug shortages.
The United States, Britain and the European Union have pledged to provide a combined $10 billion to assist in the relief of the pandemic.
A group of Chinese pharmaceutical firms have also announced they will provide medicines in bulk.
Drug shortages in India have led to an estimated 500,000 deaths and millions of infections.
As of January 7, more than 3,500 cases of tuberculosis and 1,400 cases of pneumonia had been reported across the nation, while 5,700 cases of HIV had been recorded in the last 24 hours.
Earlier this month, India’s health ministry said more than 50 per cent of the nation’s hospitals had not received the latest vaccines and other medicines required for the pandemics, leading to serious health problems.
Since the pandemer started, India has reported more than 8,000 new cases of TB and almost 5,000 cases of infections, with nearly 30,000 people dying from the disease.